To access the MOC assessment, please login and press the green "Get Started" button at the bottom of this page.

Objectives
As a result of this activity, participants will be able to:

  • Recognize drugs with and without evidence-based clinical pharmacogenomic implications.
  • Utilize the Nemours Clinical Pharmacogenomics Service and their tools such as clinical decision support and educational materials.

Practice Changes
As a result of this activity, participants will be able to:

  • Apply the Epic Genomic Indicators activity and pharmacogenomics drug-gene interaction OurPractice advisories to personalize a patient's their medication treatment.

Team-Based Learning Objective
As a result of this activity, the interprofessional team will be able to:

  • Personalize medication treatment to include pharmacogenomic implications along with the patient's and family's preferences, clinical factors, and environmental influences.

PDF icon To view additional information on the Nemours Children's disclosure policy, right click on this link to open in a new window.

All relevant financial relationships have been mitigated.

Session date: 
10/14/2026 - 8:00am to 9:00am EDT
Location: 
NCHFL Auditorium or Microsoft Teams
FL
United States
See map: Google Maps
Add to calendar: 
  • 1.00 MOC ABP - Pediatrics
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Kelsey Cook, PharmD, BCPS

has no relevant financial relationships to disclose at this time.

Benjamin Duong, PharmD

has no relevant financial relationships to disclose at this time.